Skip to Main Content

It seems like ages since President Trump castigated drug company executives for “getting away with murder” and promised to take on the powerful pharma lobby.

While the spotlight has shifted (and the threat of a crackdown has dimmed), the pharma industry still has plenty on its plate. The man charged with pushing the industry’s agenda is Stephen J. Ubl, the president and CEO of the PhRMA trade group. He stopped by the STAT offices in Boston this week to talk about his plans — and the challenges he’s confronting. Here are the highlights:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • You give front page space to Big Pharma’s highest paid Liar? And you have some rookie do the “interview?” Did Ed Silverman throw up? This is not journalism, this is pandering to advertisers. Shame on WHOEVER thought this was a good idea!

Comments are closed.